Showing results 91 to 110 of 162
< previous
next >
Issue Date | Title | Author(s) |
Jun-2013 | Mechanisms Responsible for Nilotinib Resistance in Human Chronic Myeloid Leukemia Cells and Reversal of Resistance | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Baran, Yusuf |
2015 | Mesenchymal Stem Cells Administered Intraperitoneally Have a Potent Effects on the Experimental Allergic Airway Disease | Işık, S.; Adan, Aysun ; Karaman, M.; Kiray, M.; Bağrıyanık, H. A.; Çağlayan-Sözmen, S.; Uzuner, N.; Baran, Yusuf |
Aug-2011 | Mesenchymal Stem Cells Ameliorate the Histopathological Changes in a Murine Model of Chronic Asthma | Fırıncı, Fatih; Karaman, Meral; Baran, Yusuf ; Bağrıyanık, Alper; Arıkan Ayyıldız, Zeynep; Kiray, Müge; Kozanoglu, İlknur; Yılmaz, Osman; Uzuner, Nevin; Karaman, Özkan |
2015 | The Microarray Gene Profiling Analysis of Acute Promyelocytic Leukemia Cells in Response To Fisetin and Hesperetin | Adan Gökbulut, Aysun ; Baran, Yusuf |
2023 | Micrornas and Long Non-Coding Rnas as Novel Targets in Anti-Cancer Drug Development | Çetinkaya, Melisa; Baran, Yusuf |
2018 | A Minimally Invasive Transfer Method of Mesenchymal Stem Cells To the Intact Periodontal Ligament of Rat Teeth: a Preliminary Study | Gül Amuk, Nisa; Kurt, Gökmen; Kartal Yandım, Melis; Adan, Aysun ; Baran, Yusuf |
Apr-2013 | Mir-17 in Imatinib Resistance and Response To Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Cells | Fıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf |
Feb-2016 | A Molecular and Biophysical Comparison of Macromolecular Changes in Imatinib-Sensitive and Imatinib-Resistant K562 Cells Exposed To Ponatinib | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
Jul-2016 | Molecular Mechanisms of Drug Resistance and Its Reversal in Cancer | Kartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf |
Aug-2014 | Molecular Mechanisms of Quercitrin-Induced Apoptosis in Non-Small Cell Lung Cancer | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
2014 | Multidrug Resistance in Chronic Myeloid Leukemia | Ünlü, Miray ; Kiraz, Yağmur ; Kacı, Fatma Necmiye; Özcan, Mehmet Ali; Baran, Yusuf |
Feb-2009 | Multidrug Resistance Mediated by Mrp1 Gene Overexpression in Breast Cancer Patients | Abaan, Ogan Demir; Mutlu, Pelin Kaya; Baran, Yusuf ; Atalay, Can; Gündüz, Ufuk |
2012 | A Natural Product, Quercetin Enhances the Cytotoxic and Apoptotic Effects of Dexamethasone on Jurkat Cells | Baran, Yusuf ; Kartal, Melis; Kozanoğlu, İlknur |
Feb-2013 | New Indication for Therapeutic Potential of an Old Well-Known Drug (propranolol) for Multiple Myeloma | Kozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf |
Oct-2015 | Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic Fashion | Katgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden |
Feb-2010 | Nilotinib Significantly Induces Apoptosis in Imatinib Resistant K562 Cells With Wild-Type Bcr-Abl, as Effectively as in Parental Sensitive Counterparts | Ekiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf |
2009 | Nilotinib Significantly Induces Apoptosis in Imatinib Resistant K562 Cells, as Effectively as in Parental Sensitive Counterparts | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan |
2012 | A Novel Agent, Kl-21, Has Significant Anticancer Potential on Chronic Lymphocytic Leukemia Cells but Not on Healthy Cells | Baran, Yusuf ; Gökbulut, Aysun ; Yaşar, M. |
Jan-2013 | Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer | Adan Gökbulut, Aysun ; Kartal Yandım, Melis; İskender, Güniz; Baran, Yusuf |
2014 | A Novel Biomarker for Drug Resistance in Chronic Myeloid Leukemia: Microrna-17 | Baran, Yusuf ; Fıratlıgil, Burcu ; Kartal Yandım, Melis; Kiraz, Yağmur ; Kozanoğlu, İlknur; Özdoğu, Hakan; Ünal, Ali |